This document summarizes the synthesis of indenyl ruthenium complexes for potential use as anti-cancer drugs. The author synthesized a series of indenyl ruthenium complexes containing phosphine and phosphite ligands using air-sensitive techniques. The complexes were characterized using NMR spectroscopy and one complex, IndRu(PPh3)2Cl, was found to be a more efficient catalyst than RuCl2(PPh3)3 in an oxidation reaction based on higher conversion percentage and turnover frequency. Future work may involve computational analysis of the complexes and further investigation of their catalytic and DNA-binding properties.